2don MSN
Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...
Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
Soy Nómada on MSN
New TIL therapy shows promise for advanced melanoma
A new study shows that TIL therapy, a personalized immunotherapy using a patient's own immune cells, significantly improves ...
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
2don MSN
Why some breast cancers evade treatment: Protein secreted by T cells may explain resistant tumors
Up to 20% of hormone receptor-positive breast cancers don't respond to antiestrogen therapies. A study led by researchers at ...
New research suggests the targeted radiation treatment may reduce long-term side effects while maintaining strong cancer ...
Please provide your email address to receive an email when new articles are posted on . A new multidisciplinary tumor board focuses on cancer pain, with an emphasis on bone metastases. The goals are ...
Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...
February is filled with reminders of love and health. Beyond Valentine’s Day, February is an “awareness month” for both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results